Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
09/2001
09/06/2001US20010019718 Use of polymers as film-forming barrier materials
09/06/2001US20010019715 Administering a cytotoxic T-lymphocyte and one agent capable of neutralizing or down regulating the activity of tumor secreted immunosuppressive factors
09/06/2001US20010019712 Interferon and one fatty acid moiety covalently attached to the cytokine that enhances cutaneous delivery; treating infections or enhancing an immune response
09/06/2001US20010018916 Process and device for inhalation of particulate medicaments
09/06/2001DE19962251A1 Lozenge with thermally neutral dissolution properties containing active substance with exothermic dissolution behavior and compensatory adjuvant with endothermic dissolution behavior
09/06/2001DE10009423A1 Cosmetic or pharmaceutical preparation especially for treatment of cellulite comprises nerve fibre stimulator or depolariser, phosphodiesterase inhibitor and antiestrogen
09/06/2001DE10008307A1 Micro- and nano-capsules with cationic charges on surface are used in laundry and other detergents, skin cleansers, shampoos and skin and hair cosmetics
09/06/2001DE10007816A1 Verfahren zur Herstellung von Nanosuspensionen A process for the preparation of nanosuspensions
09/05/2001EP1130037A1 Process for obtaining polymers derived from vinyl acetate, and uses thereof
09/05/2001EP1129771A1 Microcapsules
09/05/2001EP1129724A2 Vaccines for treating colon cancer
09/05/2001EP1129723A1 Combined vaccine against both hav and measle virus and method of producing it
09/05/2001EP1129720A2 Stabilized granulocyte colony stimulating factor
09/05/2001EP1129713A1 Veterinary compositions for the treatment of parasitic diseases
09/05/2001EP1129709A2 Pharmaceutical composition based on ibuprofen and a procedure for the preparation thereof
09/05/2001EP1129705A1 Powder formulation for inhalation
09/05/2001EP1129704A1 Process for targeted administration of active agents on the central nervous system
09/05/2001EP1129700A2 Composite structure with an adhesive matrix containing one or more active substances
09/05/2001EP1129694A1 Use of components for modifying physico-chemical properties of the skin and/or the mucosal tissue as adhesion prevention/decreasing adhesion agents for microorganisms
09/05/2001EP1129209A2 Polymer grafting by polysaccharide synthases
09/05/2001EP1129201A1 Lysozyme fusion proteins in infections
09/05/2001EP1129094A2 Therapeutic polymorphs of a gaba-a alpha-5 inverse agonist and pamoate formulations of the same
09/05/2001EP1129079A2 2,4-disubstituded triazine derivatives with anti hiv activity
09/05/2001EP1129064A1 Transfection reagents
09/05/2001EP1128835A1 Cyanocobalamin (vitamin b 12?) treatment in allergic disease
09/05/2001EP1128831A1 Pharmaceutical moxifloxacin preparation
09/05/2001EP1128827A1 Pharmaceutical composition for modified release insulin sensitiser
09/05/2001EP1128826A1 Chromone enteric release formulation
09/05/2001EP1128824A1 Ionic silver complex
09/05/2001EP1128821A1 A capsule based drug delivery system
09/05/2001EP1128820A1 Pharmaceutical mixture comprising a combination of a profen and other active compounds
09/05/2001EP1128819A1 New controlled release bead, a method of producing the same and multiple unit formulation comprising it
09/05/2001EP1128818A1 Functionalized nanocrystals and their use in detection systems
09/05/2001EP1128817A1 Microparticles containing peg and/or peg glyceryl esters
09/05/2001EP1128816A1 Polyvinyl alcohol microspheres, and methods for making and therapeutic uses of the same
09/05/2001EP1128815A1 Process for preparing oral calcium compositions
09/05/2001EP1128814A1 Aerosols comprising nanoparticle drugs
09/05/2001EP1128813A1 An inhalation system
09/05/2001EP1128812A1 Nano-emulsion of 5-aminolevulinic acid
09/05/2001EP1128811A1 Drug delivery device, especially for the delivery of progestins and estrogens
09/05/2001EP1128810A1 Drug delivery device, especially for the delivery of androgens
09/05/2001EP1128809A1 Aqueous ophthalmic formulations comprising chitosan
09/05/2001EP1128800A1 Flavour blend for masking unpleasant taste of zinc compounds
09/05/2001EP1128731A1 Compositions of restricted cells capable of rapid growth which produce proliferation suppressive materials, and uses thereof
09/05/2001EP1128730A1 Antimicrobial composition comprising an oxidoreductase and an enhancing agent of the n-hydroxyanilide-type
09/05/2001EP1128725A1 Disposable premoistened wipe containing an antimicrobial protease inhibitor
09/05/2001EP0879249B1 Modified inulin
09/05/2001EP0804162B1 Butylene oxide-ethylene oxide block copolymer surfactants as stabilizer coatings for nanocrystal formulation
09/05/2001EP0760677B1 A pharmaceutical preparation comprising glucagon
09/05/2001EP0746334B1 Pharmaceutical preparation containing plasminogen activators
09/05/2001EP0744938B1 Liquid ophthalmic sustained release delivery system
09/05/2001EP0642326B1 Non-fibrogenic, alginate-coated transplants, process of manufacture and method of use thereof
09/05/2001CN1311798A Method for producing powder-shaped cross-linked polymerizates
09/05/2001CN1311686A Pulmonary delivery of active agents
09/05/2001CN1311674A Antioxidant, antiproliferous compositions, comprising a carnitine and a cerotenoid
09/05/2001CN1311672A Pharmaceutical composition for injection based on paracetamol
09/05/2001CN1311669A Orally disintegrable tablet
09/05/2001CN1311668A Two-piece capsule for receiving pharmaceutical prepns. for powder inhalers
09/05/2001CN1311667A Prepn. capable of releasing drug at target side in intestine
09/05/2001CN1311666A Thermoprotected microparticle compositions and process for terminal steam sterilization thereof
09/05/2001CN1311658A Dentifrice composition contg. encapsulated reactive ingredients
09/05/2001CN1311649A Silk clothes for protecting affected parts
09/05/2001CN1311644A Apparatus and method for providing a conscious patient relief from pain and anxiety associated with medical or surgical procedures
09/05/2001CN1311257A Double specific monoclonal anti-body, its preparing method and thromobolysin made therefrom
09/05/2001CN1311189A Synthesis of poly glycol monomethyl ether cholesterol succinate derivative and its preparation
09/05/2001CN1311186A Deuteroporphyvin derivative, its preparing method and freeze dried preparation for injection
09/05/2001CN1311018A Chinese herbal plaster for anti-cancer and analgesic
09/05/2001CN1311012A Preparing method for auxiliary feedback treatment of disease medicine
09/05/2001CN1311010A Smoke inhaling article for medical use, and its mfg. method
09/05/2001CN1311008A Chinese angelica root oil soft capsule and its preparing process
09/05/2001CN1311000A Mifepristone capsule and its preparing method
09/05/2001CN1070377C Notoginseng medicinal oral liquid
09/05/2001CN1070376C External use medicinal liquor for treating acute moist wart and prepn. method therefor
09/05/2001CN1070374C Traditional Chinese medicinal prepn. for treating various kinds of pustule, lump and ulceration
09/05/2001CN1070372C Powerful anti-cancer plaster and its prepn. method
09/05/2001CN1070370C Crystalline amifostine compositions and process for prepn. of same and use thereof
09/05/2001CN1070367C Injection adhesion and method for preparing same
09/05/2001CN1070364C Cosmetic or skin-care composition of emulsion of oil covered with water formed with oil drops covered with liquid
09/04/2001US6284941 Bandage having a scar treatment pad for scar management and scar repair
09/04/2001US6284862 Monomers derived from hydroxy acids and polymers prepared therefrom
09/04/2001US6284805 Aqueous solution of an acid addition salt of a 1-alkyl-n-(2,6-dimethylphenyl)-2-piperidinecaboxamide, wherein the solution is buffered.
09/04/2001US6284804 Intended for application to the eye, ear or nose
09/04/2001US6284803 Copolymerized units a) 15-83% by weight of at least one n-vinyllactam, b) 15-83% by weight of methyl methacrylate, c) 2-70% by weight of at least one other monomer
09/04/2001US6284797 Capsaicin; norepinephrine inhibitor and a vasodilator which act to promote blood circulation in the treatment area
09/04/2001US6284792 Formulation of valnemulin
09/04/2001US6284765 (+) naloxone and epinephrine combination therapy
09/04/2001US6284745 Gel compositions
09/04/2001US6284744 Mixture of drug and hyaluronic acid; abdomen surgery
09/04/2001US6284741 Genetic engineered nucleic acid
09/04/2001US6284738 Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
09/04/2001US6284725 Administering binding compound for glucagon receptor such asglucagon-like peptide
09/04/2001US6284452 Administering aqueous solution containing potassium, magnesium, sodium, calcium, chloride, oncotic agent, carboxylic acid or salt, sugar and clotting factor
09/04/2001US6284375 Useful in variety of biomedical applications including drug delivery, vaccine targeting, drug distribution and uptake, membrane protein reconstitution, enzyme immobilization and construction of artificial cells such as blood cells
09/04/2001US6284305 Applying undercoat comprising polymeric material and biologically active material to stent portion; applying discontinuous topcoat which covers less than entire surface of undercoat, topcoat comprising nonporous polymeric material
09/04/2001US6284287 For administering drugs by breathing
09/04/2001US6284283 Method of producing sub-micron particles of biologically active agents and uses thereof
09/04/2001US6284282 Method of spray freeze drying proteins for pharmaceutical administration
09/04/2001US6284280 Microparticles containing active ingredients, agents containing these microparticles, their use for ultrasound-controlled release of active ingredients, as well as a process for their production
09/04/2001US6284277 Stable freeze-dried pharmaceutical formulation
09/04/2001US6284276 Soluble form osmotic dose delivery system